German Drug Data (Deutsch)
Norwegian Drug Data (Norge)
Netherlands Drug Data (Nederlands)
Swedish Drug Data (Sverige)
Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here
epgonline.org is not responsible for content on any 3rd party website
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
| Drug class description : | Cardioselective b-blockers (beta- blockers) / thiazide diuretics (thiazides) / K+-sparing diuretics (potassium-sparing diuretics). |
| Generic Name : | Atenolol, hydrochlorothiazide, amiloride |
| Drug description : | Red and cream capsules marked with KALTEN and logo. |
| Presentation : | Capsules, atenolol 50mg, hydrochlorothiazide 25mg, amiloride hydrochloride 2.5mg. |
| Indications : | Hypertension. |
| Adult Dosage : | 1 daily. |
| Child Dosage : | Not recommended. |
| Contra Indications : | 2nd or 3rd degree AV block, sinus bradycardia, sick sinus syndrome, severe peripheral arterial disease, uncompensated cardiac failure, cardiogenic shock, hypotension, untreated phaechromocytoma. Anuria, severe or progressive renal failure. Known hypersensitivity to components. Metabolic acidosis. Hyperkalaemia (serum K+ greater than 5.5mmol/L). Diabetic nephropathy. Prinzmetal's angina. |
| Special Precautions : | Poor cardiac reserve should be controlled with digitalis and diuretics. History of bronchospasm (cardio-selective b- blockers usually have a lesser effect on airways resistance than the non-selective type but their use should also be avoided in patients with wheezing or obstructive airways disease unless there are compelling clinical reasons). Diabetes; metabolic acidosis. Asthenic symptoms. Cerebrovascular insufficiency. Renal or hepatic impairment, thyrotoxic crisis. General anaesthesia; consider withdrawal before elective surgery. Pregnancy, lactation. Withdraw gradually. Gout, diabetes, hyperlipidaemia. Monitor electrolyte levels; K+- sparing diuretics can cause hyperkalaemia in which case K+- supplements are contraindicated. |
| Interactions : | Clonidine withdrawal, verapamil, diltiazem, class I antiarrhythmics, class II calcium antagonists, cardiac depressant anaesthetics, hypoglycaemics, reserpine, other antihypertensives, ergot alkaloids, cimetidine, rifampicin, theophylline, warfarin, CNS depressants, sympathomimetics, indometacin (indomethacin). Lithium, NSAIDs, digitalis, allopurinol, |
| Adverse Reactions : | Cold extremities, sleep disturbances (particularly with the more lipophilic drugs), bradycardia, exertional tiredness, bronchospasm, heart failure, hypotension, GI upset. If unexplained dry eyes or skin rash occur withdraw gradually. Gout, photosensitivity, rash, blood dyscrasias, weakness. |
| Manufacturer : | AstraZeneca |
| Drug Availability : | (POM) |
Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.
Already Registered?
Please log-in now using our member login box.
Not a member?
Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.
Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.
As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!
REGISTER today it only takes a minute! and it's FREE
Having problems?
Use our forgotten password facility or email us at: contact@epgonline.org

Medical News Feed



